Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,547,152 |
|
|||||
| News | - | ||||||
| Day High | 19.43 | Low High |
|||||
| Day Low | 18.23 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cullinan Therapeutics Inc | CGEM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.36 | 1.91% | 19.25 | 18:11:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.30 | 18.23 | 19.43 | 19.25 | 18.89 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,055 | 1,547,152 | $ 19.10 | $ 29,557,015 | - | 7.64 - 20.62 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:31:54 | priorref | 51,800 | $ 19.25 | USD |
Cullinan Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 829.01M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cullinan Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGEM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.00 | 19.55 | 15.20 | 16.95 | 995,050 | 1.25 | 6.94% |
| 1 Month | 17.79 | 20.62 | 15.20 | 17.15 | 681,357 | 1.46 | 8.21% |
| 3 Months | 15.14 | 20.62 | 14.98 | 17.31 | 554,545 | 4.11 | 27.15% |
| 6 Months | 8.52 | 20.62 | 7.64 | 14.99 | 382,006 | 10.73 | 125.94% |
| 1 Year | 10.59 | 20.62 | 7.64 | 13.35 | 312,403 | 8.66 | 81.78% |
| 3 Years | 31.62 | 37.60 | 7.30 | 14.94 | 276,178 | -12.37 | -39.12% |
| 5 Years | 42.00 | 59.85 | 7.30 | 17.33 | 278,151 | -22.75 | -54.17% |
Cullinan Therapeutics Description
| Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. |
